University of Hertfordshire

From the same journal

By the same authors

View graph of relations
Original languageEnglish
JournalThe Pharmaceutical Journal
Journal publication date28 Nov 2017
DOIs
Publication statusPublished - 28 Nov 2017

Abstract

The judgment in Montgomery v Lanarkshire (Scotland) 2015 introduced a new definition of informed consent which has implications for all healthcare professionals. This article focuses specifically on the implications for pharmacy practice and patients with learning disability. During consultations, both pharmacist prescribers and non-prescribing pharmacists must adhere to the provisions of the judgment to ensure patients provide informed consent. Particular issues arise where patients with learning disability are concerned because the Accessible Information Standard (AIS), which came into force in England in August 2016, must also be considered. Consequently, easy-read material should also be of a standard and quality relevant to that particular individual. In addition, this article will briefly consider whether information should always be disclosed.

Notes

Danielle Adams and Claudia Carr, 'The implications of the Montgomery judgment on pharmacy practice and patients with learning disability', the Pharmaceutical Journal, Clinical Pharmacist, CP November 2017 online, online | DOI: 10.1211/CP.2017.20203788. Copyright Royal Pharmaceutical Society 2017.

ID: 12848039